Evidence map›Paper›PMID 31632364›Full record

ArticleFrontiers in microbiology2019

HIV Infected T Cells Can Proliferate

Andrew Musick, Jonathan Spindler, Eli Boritz, Liliana Pérez, Daniel Crespo-Vélez, Sean C Patro, Michele D Sobolewski, Michael J Bale, Carolyn Reid, Brandon F Keele and 9 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Proviruses in CD4Science translational medicine · 2025
    Article
  5. Review
  6. Review
  7. HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Substantial uneven proliferation of CD4Journal of virus eradication · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Andrew MusickHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
Jonathan SpindlerHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
Eli BoritzVirus Persistence and Dynamics Section, Vaccine Research Center, National Institute for Allergies and Infectious Diseases (NIAID), Bethesda, MD, United States.
Liliana PérezVirus Persistence and Dynamics Section, Vaccine Research Center, National Institute for Allergies and Infectious Diseases (NIAID), Bethesda, MD, United States.
Daniel Crespo-VélezVirus Persistence and Dynamics Section, Vaccine Research Center, National Institute for Allergies and Infectious Diseases (NIAID), Bethesda, MD, United States.
Sean C PatroHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
Michele D SobolewskiDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Michael J BaleHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
Carolyn ReidFrederick National Laboratory for Cancer Research, Aquired Immunodeficiency Syndrome (AIDS) and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick, MD, United States.
Brandon F KeeleFrederick National Laboratory for Cancer Research, Aquired Immunodeficiency Syndrome (AIDS) and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick, MD, United States.
Adam CapoferriHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
Wei ShaoFrederick National Laboratory for Cancer Research, Advanced Biomedical Computing Center, Leidos Biomedical Research, Inc., Frederick, MD, United States.
Ann WiegandHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
Francesco R SimonettiHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
John W MellorsDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Stephen H HughesHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
John M CoffinDepartment of Molecular Biology and Microbiology, Tufts University, Boston, MA, United States.
Frank MaldarelliHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
Mary F KearneyHuman Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
Center for Cancer Research · USNational Cancer Institute · USNational Institute of Allergy and Infectious Diseases · USLeidos (United States) · USUniversity of Pittsburgh · USFrederick National Laboratory for Cancer Research · USTufts University · US

Funding

Retrovirus Evolution and CancerR35CA200421 · NCI · TUFTS UNIVERSITY BOSTON · PI COFFIN, JOHN M · 2016 to 2022
$6.5M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCI NIH HHS R35 CA200421
6 · The paper itself

Abstract

backgroundHIV-1 proviruses can persist during ART in clonally-expanded populations of CD4+ T cells. To date, few examples of an expanded clones containing replication-competent proviruses exist, although it is suspected to be common. One such clone, denoted AMBI-1 (Maldarelli et al., 2014), was also a source of persistent viremia on ART, begging the question of how the AMBI-1 clone can survive despite infection with a replication-competent, actively-expressing provirus. We hypothesized that only a small fraction of cells within the AMBI-1 clone are activated to produce virus particles during cell division while the majority remain latent despite division, ensuring their survival. To address this question, we determined the fraction of HIV-1 proviruses within the AMBI-1 clone that expresses unspliced cell-associated RNA during ART and compared this fraction to 33 other infected T cell clones within the same individual.

resultsIn total, 34 different clones carrying either intact or defective proviruses in "Patient 1" from Maldarelli et al. (2014) were assessed. We found that 2.3% of cells within the AMBI-1 clone contained unspliced HIV-1 RNA. Highest levels of HIV-1 RNA were found in the effector memory (EM) T cell subset. The fraction of cells within clones that contained HIV-1 RNA was not different in clones with intact (median 2.3%) versus defective (median 3.5%) proviruses (

conclusionThese findings show that the vast majority of HIV-1 proviruses within expanded T cell clones, including intact proviruses, may be transcriptionally silent at any given time, implying that infected T cells may be able to be activated to proliferate without inducing the expression of the integrated provirus or, alternatelively, may be able to proliferate without cellular activation. The results of this study suggest that the long, presumed correlation between the level of cellular and proviral activation may not be accurate and, therefore, requires further investigation.

Indexed as

CARD-SGScell-associated HIV RNAexpanded clonesHIV reservoirlatentlatently-infected cellsproviral expressionSGA

Identifiers

PMID31632364
PMCPMC6781911
OpenAlexW2978963496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.